SEIA
ALXN

Signature Estate & Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Signature Estate & Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-198,908
Closed -$26.1M – 167
2019
Q2 		$26.1M Buy
198,908
+32,786
+20% +$4.29M 1.72% 16
2019
Q1 		$22.5M Buy
+166,122
New +$22.5M 1.51% 27